Long-term Study in Chronic Kidney Disease (Extension From Study 14817)

Summary

The objective of this study is to investigate the safety and the effect on reduction of serum phosphate of long-term administration of lanthanum carbonate (BAY77-1931) 750 to 2250 mg in patients with hyperphosphatemia who completed the 8 week double-blind treatment period of Study 14817 and are judged to be eligible for the long-term extension study.

Timeline

Start

2010-09

Primary completion

2013-04

Completion

2013-04

Drugs

Indications